3 Houston universities rise to the top in new list of best Texas schools for 2024

top schools

UH ranked No. 8 in Texas. Photo courtesy of University of Houston

Houston universities are ramping up high quality educational experiences for their students as three local universities earn top 10 ranks for the best Texas colleges in 2024, according to a new report by U.S. News and World Report.

Rice University claimed the top spot in Texas, and ranked No. 17 in the national ranking. Houston's "Ivy League of the South" had an undergraduate enrollment of nearly 4,500 students in fall 2022. In April, Rice's Jones School of Business ranked No. 2 in U.S. News' ranking of the best graduate programs in Texas.

According to Rice's profile, the university also prides itself as a top-tier research institution. In fact, Rice just opened a massive new research facility on campus.

A degree from Rice University in Houston was ranked most valuable in the state of Texas. Rice University

"From your first semester on campus, no matter your major, you'll have the opportunity to conduct research alongside experts," the school said. "You'll be able to apply your skills, gain valuable professional experience and interact with industry leaders as you address real-world issues."

The University of Houston ranked No. 8 in the Texas rankings, and No. 133 in the national report. With a total undergraduate enrollment of nearly 38,000 students in fall 2022, U.S. News says the university has a rich campus culture that encourages students to participate in different organizations and activities.

"Each year, students turn the campus into a town called Fiesta City in time for the Frontier Fiesta, a string of concerts, talent shows, cook-offs and more," U.S. News' overview said. "There are more than 400 student organizations to check out, including fraternities and sororities."

Completing the Texas top 10 is the University of St. Thomas, which ranked No. 216 nationally. The private Catholic university has the smallest fall 2022 undergraduate enrollment out of all three Houston universities: 2,729 students.

Elsewhere in Texas, nearby Texas A&M University in College Station earned the title for the third-best college in Texas, and No. 47 in the nation. That's big news for one of the fastest-growing college towns in the U.S.

U.S. News' top 10 best colleges in Texas in 2024 are:

  • No. 1 – Rice University, Houston
  • No. 2 – University of Texas at Austin
  • No. 3 – Texas A&M University, College Station
  • No. 4 – Southern Methodist University, Dallas
  • No. 5 – Baylor University, Waco
  • No. 6 – Texas Christian University, Fort Worth
  • No. 7 – The University of Texas at Dallas, Richardson
  • No. 8 – University of Houston
  • No. 9 – Texas Tech University, Lubbock
  • No. 10 – University of St. Thomas, Houston

The full rankings can be found on usnews.com.

------

This article originally ran on CultureMap.

From Your Site Articles
Rice has been heralded again by Princeton Review. Photo courtesy of Rice University

Rice University named one of the greatest schools in U.S. in prestigious new report

RICE RISES AGAIN

Just mere weeks after being named the No. 7 university in the nation, a local hall of higher learning has just landed on yet another prestigious list.
Rice University has scored high marks in the Princeton Review's annual survey on the nation's best colleges. The new report as part of "The Best 387 Colleges," its 30th annual snapshot of academic excellence at colleges and universities.

The new report analyzes three decades of reviews on America's institutions of higher education and is based upon reviews submitted by more than 150,000 students nationwide, per a release. The survey lists the top-ranking schools measured in dozens of different categories.

For its 2022 anniversary edition, Princeton Review analyzed which colleges and universities have "the most impressive history of appearances" since 1992.

Notably, per a press release, only four institutions were named to 11 of what the review calls its "Great Lists" — and one of those schools is Rice.

To generate this report, Princeton Review analyzed three criteria: the number of times a college appeared on lists since 1992, its numerical rank on those lists, and the overall consistency of feedback from the college's students over the three decades.

Specifically, Rice ranked on the "Great Lists" in the following categories:

  • great race/class interaction
  • great financial aid
  • great health services
  • great-run colleges
  • most loved colleges
  • great college newspapers
  • great college dorms
  • great quality of life
  • great town-gown relations
  • LGBTQ-friendly
  • happy students

Rice students praised the university's faculty and described a "high quality of life" and are among "the happiest students in the United States," according to a press release.

"I wanted my college years to be both happy and successful," one student wrote in the survey. "And I found no other schools that were as prestigious, but also dedicated to ensuring the happiness of the student body."

As CultureMap previously reported, Niche ranked Rice No. 7 in its latest ratings of the best colleges in the U.S. and No. 1 in Texas.

Rice also ranked No. 136 internationally in The Wall Street Journal/Times Higher Education World University Rankings for 2022.

------

This article originally ran on CultureMap.

The device is lighter than a Band-Aid and could be used as robot skin to track movement and health conditions. Photo via uh.edu

University of Houston professors identify super thin wearable device

Data collecting skin

Imagine a wearable device so thin it's less noticeable and lighter than a Band-Aid but can track and record important health information. According to some University of Houston researchers, you might not need to imagine it at all.

A recent paper, which ran as the cover story in Science Advances, identified a wearable human-machine interface device that is so thin a wearer might not even notice it. Cunjiang Yu, a Bill D. Cook associate professor of Mechanical Engineering at the University of Houston, was the lead author for the paper.

"Everything is very thin, just a few microns thick," says Yu, who also is a principal investigator at the Texas Center for Superconductivity at UH, in a release. "You will not be able to feel it."

The device is reported in the paper to be made of a metal oxide semiconductor on a polymer base. It could be attached to a robotic hand or prosthetic, as well as other robotic devices, that can collect and report information to the wearer.

"What if when you shook hands with a robotic hand, it was able to instantly deduce physical condition?" Yu asks in the release.

The device could also be used to help make decisions in situations that are hazardous to humans, such as chemical spills.

Current devices on the market or being developed are much slower to respond and bulkier to wear, not to mention expensive to develop.

"We report an ultrathin, mechanically imperceptible, and stretchable (human-machine interface) HMI device, which is worn on human skin to capture multiple physical data and also on a robot to offer intelligent feedback, forming a closed-loop HMI," the researchers write in the paper. "The multifunctional soft stretchy HMI device is based on a one-step formed, sol-gel-on-polymer-processed indium zinc oxide semiconductor nanomembrane electronics."

The paper's co-authors, in addition to Yu, include first author Kyoseung Sim, Zhoulyu Rao, Faheem Ershad, Jianming Lei, Anish Thukral, and Jie Chen, who are all from UH; Zhanan Zou and Jianliang Xiao of the University of Colorado; and Qing-An Huang of Southeast University in Nanjing, China.


Soft Wearable Multifunctional Human-Machine Interfaces (HMIs)www.youtube.com

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston researchers develop dissolvable implant for targeted cancer drug delivery

cancer research

Researchers at Houston Methodist have developed a biodegradable implant that can be used to safely and consistently deliver drug treatments to tumors and then dissolve without the need for further surgery.

The implant is only the size of a grain of rice, but its potential is staggering. The biodegradable nanofibrous drug-eluting seed (b-NDES) works as a reservoir parked inside a soft tumor, where it can slowly release immune-stimulating drugs over time. This overcomes a consistent problem with drugs such as immune checkpoint inhibitors. Normal systemic administration sees comparatively little of the drug making its way to the tumor, with most of it circulating throughout the body. The b-NDES is like deploying a small guerrilla fighting force embedded in enemy territory, doing maximum damage to the entrenched tumor.

"To improve cancer treatment, we're trying to start a fire inside the tumor itself," Corrine Chua, associate professor in the Center for BioNanoengineering at Houston Methodist Research Institute, said in a news release. "By activating immune cells directly within the tumor microenvironment, those cells can then travel throughout the body and seek out cancer wherever it exists. The b-NDES platform was developed to help keep therapeutic drugs concentrated inside tumors while minimizing exposure to healthy tissues.”

Chua co-led the study with Alessandro Grattoni, chair and director of the Center for BioNanoengineering at Houston Methodist Research Institute.

The study included support from the Nancy Owens Breast Cancer Foundation and the National Institutes of Health/National Cancer Institute.

Chau and Grattoni used preclinical models of triple-negative breast cancer, an aggressive form of cancer that is estrogen receptor-negative, progesterone receptor-negative and HER2-negative. Because of the receptor negativity, some popular treatments like tamoxifen and trastuzumab are ineffective. Chemotherapy has been shown to be the best course of action.

The b-NDES implant is deployed alongside radiation drugs. It keeps the drugs focused on the tumor, reducing the amount of harmful side effects typically seen when drugs are circulated more widely in the body. In 60 percent of the models, tumors were eliminated and did not cause side effects beyond the tumor site. Once the drugs have been deployed, the implant breaks down naturally.

While promising, more research will have to be done to expand use to other tumor types.

"Although the study focused on triple-negative breast cancer models, the approach could have broader applications for solid tumors," Grattoni added in the release. "It could potentially be used in cancers where there is a tumor lesion accessible for placement, including pancreatic or lung cancers."

New Houston platform Same Day Reels launches for on-demand content creation

In The Moment

If an event doesn't happen on Instagram, did it even really happen? In today's social media-driven age of branding and audience engagement, the answer increasingly is no.

Houston entrepreneur Karen De Amat is looking to fill the online content creation needs of companies with her new venture, Same Day Reels, which launched in early August. It will serve as a platform to connect companies and brands with talent that can help turn an event into a viral moment as it is happening.

"Events move quickly, and social media moves even faster,” said De Amat. “Same Day Reels was built to help brands capture the moment while it still matters. We are creating a more efficient way for businesses and creators to work together. Brands need content faster, and creators need more opportunities to turn their talent into real work. Same Day Reels brings those needs together.”

The company is focused on adding livestreams and concurrent short video content to "activations, launches, fundraisers, grand openings, conferences, hospitality experiences, and private celebrations." Such content can significantly increase the visibility of a product or brand according to digital marketing brands like Wyzowl, whose data found 63 percent of people in 2026 prefer to learn about new products via short video.

Packages offered by Same Day Reels will include filming, editing, and publishing content within hours of the targeted event.

De Amat says that her content creation platform will be a way to preserve the excitement of events and launches by enshrining them with immediate social media-driven memories.

“Event content is no longer just something you post after the fact,” De Amat said. “It is part of how people experience, remember and share the moment.”

Previously, De Amat is also the founder and CEO of Social Behavior, an influencer marketing company she launched from her home in 2014. It quickly garnered an array of clients and thrust De Amat into the spotlight, including numerous appearances on Fox 26's The Isiah Factor. Influencer Marketing Hub named her one of the top CEOs of influencer marketing companies in Houston in 2025.

---

This article originally appeared on CultureMap.com.

Bristol Myers Squibb to build $2.3B Houston pharma manufacturing campus

coming soon

New Jersey-based pharmaceutical giant Bristol Myers Squibb Co. has officially named Houston as the home of its new state-of-the-art manufacturing site.

The 60,000-square-foot facility represents a $2.3 billion investment, according to a news release. It is expected to create 500 skilled jobs and will be located in Houston's Generation Park.

BMS first announced that it was considering Houston among 16 other cities for the facility in May. The new hub will manufacture small molecule, biologic and antibody-drug conjugates and is part of a $40 billion commitment to invest in the United States over five years. Construction is slated to begin next year, with the facility coming online in 2030.

"We're building the domestic manufacturing capabilities needed to deliver the next generation of medicines and support future scientific breakthroughs. Houston and the state of Texas offer the talent, infrastructure, and partnership needed to help bring that vision to life," Christopher Boerner, CEO and board chair of BMS, said in the release.

The new facility will feature a modular, multi-modal design, which will allow the company to reconfigure and add to its manufacturing capabilities over time. BMS says it expects the facility to "(grow) in scale and capability well beyond its opening configuration."

"Our decision to build this state-of-the-art manufacturing campus in Houston, Texas, reflects our confidence in the region’s ability to support a world-class, digitally advanced supply operation,” Karin Shanahan, EVP and chief supply chain and operations officer of BMS, added in the release. “This facility is designed to deliver the speed, quality, and reliability that patients depend on, combining flexible, modular manufacturing with advanced digital capabilities to ensure consistent supply across multiple modalities. It strengthens our ability to operate with resilience and positions us to reliably deliver medicines to patients today while adapting future demands.”

Texas Gov. Greg Abbott shared that the state has granted BMS a $4.89 million Texas Enterprise Fund (TEF) grant for the project. TEF grants, administered by the Texas Economic Development & Tourism Office, support business relocation or expansion projects that create "new, good-paying jobs in the community and attract significant new capital investment to the state." The development is also a qualified project under the Texas Jobs, Energy, Technology, and Innovation (JETI) program.

“Texas is a global hub for life sciences, where today’s innovations shape the future of healthcare,” Abbott said in a news release. “This $2.3 billion investment by Bristol Myers Squibb in the dynamic biotech ecosystem in Houston is a testament to the depth of our skilled workforce and the pipeline of talent coming through our nation-leading technical colleges and research universities. With lower operating costs and easy access to markets across the U.S. and the world, Texas drives affordability for consumers.”

"Bristol Myers Squibb’s announcement is a tremendous win for Texas and the Houston region, further reinforcing our position as a premier destination for life sciences and advanced manufacturing,” added Greater Houston Partnership President and CEO Steve Kean.

Last fall, Eli Lilly and Co. selected Generation Park, a 4,300-acre, master-planned commercial district near Lake Houston, for its $6.5 billion manufacturing plant. More than 300 locations in the U.S. competed for the factory. Read more here.

View All Listings